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Abstract
Background: The prognostic influence of hyperglycemia in acute stroke has been well established. While in cortical
stroke there is a strong association between hyperglycemia and poor outcome, this relation is less clear in lacunar
stroke. It has been suggested that this discrepancy is present among patients treated with intravenous tissue
plasminogen activator (tPA), but confirmation is needed.
Methods: In two prospectively collected cohorts of patient treated with intravenous tPA for acute ischemic stroke,
we investigated the effect of hyperglycemia (serum glucose level >8 mmol/L) on functional outcome in lacunar
and non-lacunar stroke. Poor functional outcome was defined as modified Rankin Scale score ≥ 3 at 3 months.
Results: A total of 1012 patients was included of which 162 patients (16 %) had lacunar stroke. The prevalence of
hyperglycemia did not differ between stroke subtypes (22 % vs 21 %, p = 0.85). In multivariate analysis
hyperglycemia was associated with poor functional outcome in non-lacunar stroke (OR 2.1, 95 % CI 1.39–3.28,
p = 0.001). In patients with lacunar stroke, we did not find an association (OR 1.8, 95 % CI 0.62–4.08, p = 0.43).
Conclusion: This study confirms a difference in prognostic influence of hyperglycemia between non-lacunar and
lacunar ischemic stroke.
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Background
Admission hyperglycemia is common in patients with
acute ischemic stroke and occurs among all ischemic
stroke subtypes [1]. Acute ischemic stroke can give rise
to abnormalities in glucose metabolism inducing a stress
hyperglycemia, also in non-diabetic patients [2]. Admis-
sion hyperglycemia is strongly associated with poor
functional outcome after ischemic stroke, regardless of a
history of diabetes [3–10]. In patients treated with intra-
venous recombinant tissue plasminogen antigen (tPA),
hyperglycemia was associated with lower recanalization
rates, poor functional outcome, higher mortality and in-
creased risk of symptomatic intracerebral hemorrhage
(SICH) [3–10].
Two previous studies found that the prognostic value
of admission hyperglycemia differed among ischemic
stroke subtypes. Hyperglycemia was associated with poor
outcome in patients with large vessel stroke, but a favor-
able effect of moderate hyperglycemia was suggested in
lacunar stroke [7, 9]. Both studies investigated patients
that did not receive thrombolytic therapy. Hypergly-
cemia is thought to augment reperfusion injury by in-
creased oxidative stress and inflammatory respons [11].
Furthermore, in large vessel stroke hyperglycemia was
associated with reduced salvage of the penumbra and
larger infarct size [6].
It could be expected that in patients treated with intra-
venous tPA the difference in functional outcome be-
tween these two stroke subtypes would be even more
striking, because hyperglycemia is associated with reper-
fusion injury. Moreover this information could be used
to guide the setup of additional clinical trials investigat-
ing the role of blood glucose lowering therapy in tPA
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treated patients. Recently, a post-hoc analysis of the
NINDS dataset confirmed this hypothesis [12]. Mandava
et al. showed that hyperglycemia was associated with
worse functional outcome in patients with large vessel
occlusive stroke, where as in small vessel occlusive
stroke no difference in outcome between normoglycemic
and hyperglycemic patients was found. However, ex-
trapolation of these results may be hampered by the
small patient group sizes. We aimed to investigate the
effect of admission hyperglycemia on functional out-
come in a large cohort of patients with lacunar and non-
lacunar stroke treated with intravenous tPA. We tested
the hypothesis that admission hyperglycemia is a nega-
tive predictor of functional outcome in non-lacunar
stroke but not in lacunar stroke.
Methods
Data were obtained from two stroke centers in the
Netherlands and Belgium. Both centers have an ongoing
prospective registry of consecutive patients with acute
ischemic stroke receiving intravenous tPA treatment.
The registry was started at the University Medical Cen-
ter of Groningen (UMCG) in April 2002. All patients
registered between April 2002 and December 2013 were
included in this study. In the Universitair Ziekenhuis
Brussel (UZB), the registry was started in March 2009.
In both hospitals, tPA treatment was performed within a
time window of 4.5 h after onset of symptoms according
to a protocol which has been described earlier [13]. Ac-
cording to the local ethical boards criteria, no ethical
approval was required to use the anonymized data in the
registries.
Stroke severity before administration of tPA was
assessed according to the National Institute of Health
Stroke Scale (NIHSS). The stroke subtype was classified as
lacunar stroke (LACI = lacunar infarct) or non-lacunar
stroke (PACI = partial anterior circulation infarct, TACI =
total anterior circulation infarct and POCI = posterior cir-
culation infarct) according to the Oxfordshire Community
Stroke Project Classification (OCSP) [14].
Demographic and clinical information was recorded,
including cardiovascular risk factors and serum glucose
concentration. Blood glucose levels were determined in
a venous blood sample on admission at the emergency
room, before tPA treatment. We decided to assess the
relation between admission hyperglycemia and outcome,
because the (non-fasting) blood glucose levels during the
acute phase are most likely to influency the ischemic
penumbra in acute stroke. Hyperglycemia was defined
as >8 mmol/L (≈144 mg/dl) in accordance with previous
studies on this subject [5, 8, 12, 15].
Outcome
The modified Rankin Scale (mRS) was used to determine
functional outcome at 3 months after stroke onset. Func-
tional outcome was dichotomized into poor outcome
meaning dependence or death (mRS 3–6) and favorable
outcome (mRS 0–2), corresponding to independence with
regard to activities of daily living [16]. This cut-off score
was preferred as it allows comparison with previous
Fig. 1 Flowchart with patient characteristics
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reports on this topic [5, 7, 8]. Outcome was assessed by
experienced stroke nurses.
Statistics
Baseline characteristics for patients stratified by stroke
subtype were compared. Mann Whitney U-test was used
for continuous and ordinal variables without a normal
distribution. Pearson’s Chi Square test and Fisher’s exact
test were used for dichotomous variables. All factors
with a p-value <0.20 in baseline characteristics were also
added to the initial multivariate analysis. In the multi-
variate analysis, age and baseline NIHSS score were
added as covariates because these variables are generally
accepted as independent predictors of stroke outcome
[17]. Given the aim of the study, a history of diabetes
was also entered in the multivariable analysis and an
interaction-term between hyperglycemia and a history of
diabetes was tested. In the multivariate analysis variable
with a p value > 0.20 were removed from the final model.
All statistical analyses were performed using PASW Sta-
tistics 20.0. Statistical significance is taken to be at two
tailed level < 0.05. A binary logistic regression model is
used for multivariable analysis, with adjustment for pos-
sible confounders, to calculate odds ratios with 95 %
confidence interval.
Results
One thousand and sixty-four patients were treated with
tPA during the study period. Three month mRS scores
of 43 patients were missing (4 % of total population), 30
patients of the UMCG cohort (3 %) and 13 patients of
the UZB cohort (11 %). These patients were excluded
from the analysis. Of the remaining 1021 patients nine
patients (1 %) were excluded because of missing data on
stroke subtype according to the Oxfordshire Community
Stroke Project Classification. We included a total of
1012 patients consisting of 162 patients (16 %) with la-
cunar stroke and 850 patients (84 %) with non-lacunar
stroke. In the non-lacunar stroke group, 480 patients
(47 %) had PACI, 297 patients (29 %) TACI and 73 pa-
tients (7 %) POCI.
The baseline characteristics are presented in Table 1.
Patients with lacunar stroke were significantly younger
than patients with non-lacunar stroke and they had
lower baseline NIHSS. Patients with lacunar stroke were
more often current smokers and more frequently had a
history of hypercholesterolemia. As expected, presence
of atrial fibrillation was less common in patients with la-
cunar stroke. No difference in baseline serum glucose
levels were found between the two stroke subtypes
(6.9 mmol/L versus 6.9 mmol/L, p = 0.78) and the occur-
rence of admission hyperglycemia, did not differ be-
tween the subtypes (22 % versus 21 %, p = 0.85). The
onset to treatment was higher in lacunar stroke.
Functional outcome
In total, 499 patients (49 %) had a poor outcome (mRS
3–6), see also Fig. 1. The occurrence of poor outcome
was significantly different between patients with lacunar
and non-lacunar stroke (22 % versus 55 %, p = < 0.001).
Univariate analysis showed that patients with lacunar
stroke and normoglycemia less frequently had poor
outcome than those with hyperglycemia (19 % versus
34 % respectively, p = 0.047). After adjustment for pos-
sible confounders in multivariate analysis, admission
hyperglycemia was not associated with poor functional
outcome (OR, 1.8; 95 % CI, 0.62–4.08; p = 0.43)
(Table 2).
In non-lacunar stroke, univariate analysis also showed
a significant difference between normoglycemic and
hyperglycemic patients with regard to poor outcome
(51 % versus 67 %, p = <0.001). The association between
admission hyperglycemia and poor outcome was con-
firmed in multivariate analysis taking possible confounders
into account (OR, 2.1; 95 % CI, 1.39–3.28; p = 0.001)
(Table 2). Older age and higher baseline NIHSS score were
associated with poor functional outcome in both stroke
subtypes (Table 2). Testing for the interaction term includ-
ing hyperglycemia and diabetes did not change the results
in the multivariate models.





Characteristic N = 162 N = 850 p-value
Male (%) 94 (58 %) 459 (54 %) 0.35
Mean age (SD), years 66 (13) 69 (14) 0.004d
Median NIHSS at presentation
(IQR)
7 (5–9) 12 (7–17) <0.001d
Mean serum glucose level (SD),
mmol/L
6.9 (2.1) 6.9 (2.3) 0.78d
Mean onset to treatment time
(SD), minutesa
164 (81) 151 (58) 0.04c
Hyperglycemia (>8 mmol/L) 35 (22 %) 178 (21 %) 0.85













Hypertension (%) 84 (52 %) 426 (50 %) 0.69
Diabetes (%) 32 (20 %) 128 (15 %) 0.13
Hypercholesterolemia (%) 103 (64 %) 460 (54 %) 0.026
Atrial fibrillation (%) 22 (14 %) 201 (24 %) 0.005
Smoking (%)c 53 (33 %) 206 (25 %) 0.04
Values are number unless otherwise indicated
IQR inter-quartile range, SD standard deviation, HDL high density lipoprotein,
LDL low density lipoprotein. a115 missing, b 248 missing, c 41 missing.
P values calculated with Pearson’s χ2-test, unless otherwise indicated.
d Mann–Whitney U-test
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Symptomatic intracerebral hemorrhage
There were 35 (3.5 %) patients in the entire cohort with
a symptomatic intracerebral hemorrhage (SICH) after
rtPA treatment. There was no significant difference in
SICH rate between lacunar and non lacunar strokes (re-
spectively 3/162 (1.9 %) versus 32/850 (3.8 %), p = 0.35).
Mean admission glucose levels were non signicantly
higher in patients SICH compared to patients without
SICH (7.4 mmol/L versus 6.8 mmol/L, p = 0.78).
Discussion
Our results show that hyperglycemia independently pre-
dicted poor functional outcome, in tPA-treated patients
with non-lacunar stroke but not in patients with lacunar
stroke. These findings are consistent with the results of
the small retrospective post-hoc study of the NINDS
dataset [12]. Higher NIHSS scores and older age were
associated with poor functional outcome in our study.
Both variables have previously been reported as prog-
nostic variables in tPA treated patients [18].
The mechanisms by which hyperglycemia augments is-
chemic brain injury are not fully understood and several
mechanisms are thought to play a role in the detrimental
effect. Hyperglycemia may have a detrimental effect in
large vessel stroke due to anaerobic glycolysis enhancing
acidosis and free radical production, increase of blood–
brain barrier permeability, increase of coagulation pro-
cesses and decreased fibrinolytic activity, and induction
of vascular changes with a pro-vasoconstrictive, pro-
thrombotic and pro-inflammatory effect which compro-
mises the collateral circulation and enhances reperfusion
injury, in the ischemic penumbra [11, 15, 19–25]. The
rather favorable functional outcome in patients with lacu-
nar stroke and moderate hyperglycemia may be related to
the absence of an ischemic penumbra [6, 7], and anaerobic
glycolysis leading to increased astrocytic production of
lactate, which is an important source of energy for axons
and oligodendrocytes [26, 27].
Furthermore, a correlation was found between higher
lactate levels in the cerebrospinal fluid and poor func-
tional outcome in patients with non-lacunar stroke, but
not in patients with lacunar stroke [28]. Plausibly, this
mechanism may counterbalance the negative effects of
hyperglycemia in lacunar stroke. It should be noted,
however, that the exact mechanisms why hyperglycemia
has a different prognostic influence in lacunar and non
lacunar stroke are not elucidated yet, and the these hy-
potheses have yet to be proven.
Trials investigating the effects of glucose lowering in
acute ischemic stroke showed mostly disappointing re-
sults. Overall, no improvement of functional outcome
was found [29, 30]. Large trials on this subject are on-
going, including patients treated with intravenous tPA.
(www.clinicaltrials.gov, e.g. ID NCT01369069).
Our study has several limitations. Despite the quite
large sample size, the subgroup of patients with lacunar
stroke is relatively small, which may negatively influence
the statistical power of our findings. Information on ser-
ial glucose measurements or glycosylated hemoglobin
concentrations were not available and we did not per-
form a MRI of the brain to confirm the clinical classifi-
cation of stroke subtype, as lacunar stroke based on the
OCSP classification is not exactly the same as small ves-
sel disease (TOAST criteria). At last, as we did not rec-
ord variables like antidiabetic medication use or body
mass index, we cannot not rule out that these variables
could have confounded our results.
Conclusion
The results of our prospective study confirm the results
of an earlier post-hoc analysis on this subject and lend
further support for a different approach of hypergly-
cemia in non-lacunar and lacunar ischemic stroke.
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Table 2 Multivariate analysis: association of hyperglycemia > 8 mmol/L and functional outcome
Poor outcome (mRS 3–6)
Lacunar stroke Non-lacunar stroke
Variables OR 95 % CI p OR 95 % CI p
Hyperglycemia, >8 mmol/L 1.58 0.62–4.08 0.34 2.10 1.39–3.28 0.001
Age, year 1.04 1.01–1.07 0.02 1.05 1.03–1.06 <0.001
NIHSS score 1.19 1.06–1.35 <0.001 1.23 1.19–1.27 <0.001
History of diabetes 1.90 0.73–5.03 0.19 1.34 0.83–2.16 0.24
CI confidence interval, mRS modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, OR odds ratio. Hosmer-Lemeshow: 0.71/0.67
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